Cutaneous reactions to intradermal prostaglandins
نویسندگان
چکیده
منابع مشابه
Reactions to prick and intradermal skin tests.
BACKGROUND Allergy skin testing is a common procedure for the diagnosis of atopic diseases with a small risk of systemic reactions. OBJECTIVE To determine the 12-month incidence of systemic reactions (SRs) to skin prick testing (SPT) and intradermal skin testing (ST) and the symptoms and response to immediate treatment with epinephrine intramuscularly. METHODS A prospective study was conduc...
متن کاملCutaneous Reactions to Penicillin.
GELL, P. G. H., HARINGTON, C. R., and PiTr-RIVERS, R. (1946): Brit. J. exp. Path., 27, 267. HEREMANS, J. F., and VAERMAN, J. P. (1962): Nature (Lond.), 193, 1091. LANDSTEINER, K., The Specificity of Serological Reactions, Harvard Univ. Press, Cambridge, Mass., Rev. Edit., 1945. LEVINE, B. B. (1960a): J. exp. Med., 112, 113. LEVINE, -B. B. (1960b): Nature (Lond.), 187, 939. LEVINE, B. B. (1960c)...
متن کاملCutaneous Reactions in Pneumonia. the Development of Antibodies following the Intradermal Injection of Type-specific Polysaccharide
The majority of patients convalescent from pneumonia due to Types I, II and III Pneumococcus develop at the time of recovery circulating antibodies for the homologous type of organisms. At the same time an immediate wheal and erythema reaction followed the intradermal injection of the homologous type-specific polysaccharide in 100 per cent of Type I patients, 58.8 per cent of Type II patients, ...
متن کاملCutaneous adverse reactions to lenalidomide.
Lenalidomide is an immunomodulatory drug (IMiD) used principally in the treatment of multiple myeloma (MM), myelodysplastic syndromes (MS) and amyloidosis. Adverse reactions related to lenalidomide include myelosuppression (mainly neutropenia but also thrombocytopenia), gastrointestinal problems, skin eruption, atrial fibrillation and asthenia, decreased peripheral blood stem cell yield during ...
متن کامل[Adverse cutaneous reactions to erlotinib].
INTRODUCTION Erlotinib is an inhibitor of human epidermal growth factor approved for treating non-small cell lung cancer. The aim of this prospective observational study was to determine the prevalence of adverse cutaneous reactions caused by erlotinib and assess the management of such effects. METHODS Eleven patients with lung cancer and 1 with ovarian cancer received erlotinib at a dose of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Pharmacology
سال: 1971
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.1971.tb09934.x